Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;5(2):146-57.

Kinetic Spectrofluorometric Determination of Certain Calcium Channel Blockers via Oxidation with Cerium (IV) in Pharmaceutical Preparations

Affiliations

Kinetic Spectrofluorometric Determination of Certain Calcium Channel Blockers via Oxidation with Cerium (IV) in Pharmaceutical Preparations

M I Walash et al. Int J Biomed Sci. 2009 Jun.

Abstract

A simple and sensitive kinetic spectrofluorometric method was developed for the determination of some calcium channel blockers namely, verapamil hydrochloride, diltiazem hydrochloride, nicardipine hydrochloride and flunarizine. The method is based upon oxidation of the studied drugs with cerium (IV) ammonium sulphate in acidic medium. The fluorescence of the produced Ce (III) was measured at 365 nm after excitation at 255 nm. The different experimental parameters affecting the development and stability of the reaction product were carefully studied and optimized. The fluorescence-concentration plots were rectilinear for all the studied compounds over the concentration range of 0.01 to 0.12 μg mL(-1). The limits of detections for the studied compounds ranged from 2.93 × 10(-3) to 0.012 μg mL(-1) and limits of quantification from 9.76 × 10(-3) to 0.04 μg mL(-1) were obtained. The method was successfully applied to the analysis of commercial tablets. The results obtained were in good agreement with those obtained with reference methods.

Keywords: Cerium (IV); diltiazem hydrochloride; nicardipine hydrochloride; verapamil hydrochloride.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structural formulae of the studied drugs.
Figure 2
Figure 2
Excitation and emission spectra of induced Ce(III) by oxidation of 0.06 μg mL-1 DLT with Ce (IV) where: (A), Excitation spectrum; (A`), Emission spectrum.
Figure 3
Figure 3
Effect of volume of 5 × 10-4 M Ce (IV) on the relative fluorescence intensity. ●, 0.06 μg mL-1 DLT; □, 0.1 μg mL-1 VP; Δ, 0.1 μg mL-1 FZ; ■, 0.1 μg mL-1 NC.
Figure 4
Figure 4
Effect of molar concentration of H2SO4 on the relative fluorescence intensity. ●, 0.06 μg mL-1 DLT; □, 0.1 μg mL-1 VP; Δ, 0.1 μg mL-1 FZ; ■, 0.1 μg mL-1 NC.
Figure 5
Figure 5
Effect of the heating time on the relative fluorescence intensity. Δ, 0.06 μg mL-1 DLT; ●, 0.1 μg mL-1 VP; □, 0.1 μg mL-1 FZ; ■, 0.1 μg mL-1 NC.
Figure 6
Figure 6
Plot of Log reaction rate (Log ΔF/Δt) versus Log concentration of: A, VP; B, DLT; C, NC; D, FZ.
Figure 7
Figure 7
Stoichiometry of the reaction between VP and Ce (IV) adopting limiting logarithmic method. A, Log (VP] vs log ΔF; B, Log (Ce (IV)] vs log ΔF.
Figure 8
Figure 8
Proposal for the reaction between VP and Ce (IV).
Figure 9
Figure 9
Proposal for the reaction between DLT and Ce (IV).
Figure 10
Figure 10
Proposal for the reaction between NC and Ce (IV).
Figure 11
Figure 11
Proposal for the reaction between FZ and Ce (IV).

Similar articles

References

    1. Parfitt K, editor. In Martindale. The Complete Drug Reference. 32th. Massachusetts: The Pharmaceutical Press; 1999.
    1. Rahman N, Hejaz A, Syed N. Farmaco. 2004;59:529–536. - PubMed
    1. Rahman N, Hoda M. Anal. and Bioanal. Chem. 2002;374:484–489. - PubMed
    1. Khalil S, Kelzieh A. J. Pharm. Biomed. Anal. 2002;27:123–131. - PubMed
    1. Esteves da Silva JCG, Leitao JMM, Costa FS, Ribeiro JLA. Anal. Chim. Acta. 2002;453:105–115.

LinkOut - more resources